197 related articles for article (PubMed ID: 21088133)
1. Transplantation of human fetal blood stem cells in the osteogenesis imperfecta mouse leads to improvement in multiscale tissue properties.
Vanleene M; Saldanha Z; Cloyd KL; Jell G; Bou-Gharios G; Bassett JH; Williams GR; Fisk NM; Oyen ML; Stevens MM; Guillot PV; Shefelbine SJ
Blood; 2011 Jan; 117(3):1053-60. PubMed ID: 21088133
[TBL] [Abstract][Full Text] [Related]
2. Potential of human fetal chorionic stem cells for the treatment of osteogenesis imperfecta.
Jones GN; Moschidou D; Abdulrazzak H; Kalirai BS; Vanleene M; Osatis S; Shefelbine SJ; Horwood NJ; Marenzana M; De Coppi P; Bassett JH; Williams GR; Fisk NM; Guillot PV
Stem Cells Dev; 2014 Feb; 23(3):262-76. PubMed ID: 24028330
[TBL] [Abstract][Full Text] [Related]
3. Upregulating CXCR4 in human fetal mesenchymal stem cells enhances engraftment and bone mechanics in a mouse model of osteogenesis imperfecta.
Jones GN; Moschidou D; Lay K; Abdulrazzak H; Vanleene M; Shefelbine SJ; Polak J; de Coppi P; Fisk NM; Guillot PV
Stem Cells Transl Med; 2012 Jan; 1(1):70-8. PubMed ID: 23197643
[TBL] [Abstract][Full Text] [Related]
4. Intrauterine transplantation of human fetal mesenchymal stem cells from first-trimester blood repairs bone and reduces fractures in osteogenesis imperfecta mice.
Guillot PV; Abass O; Bassett JH; Shefelbine SJ; Bou-Gharios G; Chan J; Kurata H; Williams GR; Polak J; Fisk NM
Blood; 2008 Feb; 111(3):1717-25. PubMed ID: 17967940
[TBL] [Abstract][Full Text] [Related]
5. Correlations Between Bone Mechanical Properties and Bone Composition Parameters in Mouse Models of Dominant and Recessive Osteogenesis Imperfecta and the Response to Anti-TGF-β Treatment.
Bi X; Grafe I; Ding H; Flores R; Munivez E; Jiang MM; Dawson B; Lee B; Ambrose CG
J Bone Miner Res; 2017 Feb; 32(2):347-359. PubMed ID: 27649409
[TBL] [Abstract][Full Text] [Related]
6. Engraftment of skeletal progenitor cells by bone-directed transplantation improves osteogenesis imperfecta murine bone phenotype.
Sinder BP; Novak S; Wee NKY; Basile M; Maye P; Matthews BG; Kalajzic I
Stem Cells; 2020 Apr; 38(4):530-541. PubMed ID: 31859429
[TBL] [Abstract][Full Text] [Related]
7. Decreasing maternal myostatin programs adult offspring bone strength in a mouse model of osteogenesis imperfecta.
Oestreich AK; Kamp WM; McCray MG; Carleton SM; Karasseva N; Lenz KL; Jeong Y; Daghlas SA; Yao X; Wang Y; Pfeiffer FM; Ellersieck MR; Schulz LC; Phillips CL
Proc Natl Acad Sci U S A; 2016 Nov; 113(47):13522-13527. PubMed ID: 27821779
[TBL] [Abstract][Full Text] [Related]
8. Are Changes in Composition in Response to Treatment of a Mouse Model of Osteogenesis Imperfecta Sex-dependent?
Boskey AL; Marino J; Spevak L; Pleshko N; Doty S; Carter EM; Raggio CL
Clin Orthop Relat Res; 2015 Aug; 473(8):2587-98. PubMed ID: 25903941
[TBL] [Abstract][Full Text] [Related]
9. Myostatin deficiency partially rescues the bone phenotype of osteogenesis imperfecta model mice.
Oestreich AK; Carleton SM; Yao X; Gentry BA; Raw CE; Brown M; Pfeiffer FM; Wang Y; Phillips CL
Osteoporos Int; 2016 Jan; 27(1):161-70. PubMed ID: 26179666
[TBL] [Abstract][Full Text] [Related]
10. Sclerostin antibody reduces long bone fractures in the oim/oim model of osteogenesis imperfecta.
Cardinal M; Tys J; Roels T; Lafont S; Ominsky MS; Devogelaer JP; Chappard D; Mabilleau G; Ammann P; Nyssen-Behets C; Manicourt DH
Bone; 2019 Jul; 124():137-147. PubMed ID: 31051315
[TBL] [Abstract][Full Text] [Related]
11. Raloxifene reduces skeletal fractures in an animal model of osteogenesis imperfecta.
Berman AG; Wallace JM; Bart ZR; Allen MR
Matrix Biol; 2016; 52-54():19-28. PubMed ID: 26707242
[TBL] [Abstract][Full Text] [Related]
12. Dietary fluoride restriction does not alter femoral biomechanical strength in col1a2-deficient (oim) mice with type I collagen glomerulopathy.
Carleton SM; Whitford GM; Phillips CL
J Nutr; 2010 Oct; 140(10):1752-6. PubMed ID: 20724489
[TBL] [Abstract][Full Text] [Related]
13. Strontium Ranelate Reduces the Fracture Incidence in a Growing Mouse Model of Osteogenesis Imperfecta.
Shi C; Hu B; Guo L; Cao P; Tian Y; Ma J; Chen Y; Wu H; Hu J; Deng L; Zhang Y; Yuan W
J Bone Miner Res; 2016 May; 31(5):1003-14. PubMed ID: 26679066
[TBL] [Abstract][Full Text] [Related]
14. Sclerostin-Antibody Treatment Decreases Fracture Rates in Axial Skeleton and Improves the Skeletal Phenotype in Growing oim/oim Mice.
Cardinal M; Dessain A; Roels T; Lafont S; Ominsky MS; Devogelaer JP; Chappard D; Mabilleau G; Ammann P; Nyssen-Behets C; Manicourt DH
Calcif Tissue Int; 2020 May; 106(5):494-508. PubMed ID: 32025752
[TBL] [Abstract][Full Text] [Related]
15. Abnormal mineral-matrix interactions are a significant contributor to fragility in oim/oim bone.
Miller E; Delos D; Baldini T; Wright TM; Pleshko Camacho N
Calcif Tissue Int; 2007 Sep; 81(3):206-14. PubMed ID: 17660935
[TBL] [Abstract][Full Text] [Related]
16. Bone marrow stromal cells contribute to bone formation following infusion into femoral cavities of a mouse model of osteogenesis imperfecta.
Li F; Wang X; Niyibizi C
Bone; 2010 Sep; 47(3):546-55. PubMed ID: 20570757
[TBL] [Abstract][Full Text] [Related]
17. Growth hormone injections improve bone quality in a mouse model of osteogenesis imperfecta.
King D; Jarjoura D; McEwen HA; Askew MJ
J Bone Miner Res; 2005 Jun; 20(6):987-93. PubMed ID: 15883639
[TBL] [Abstract][Full Text] [Related]
18. The synergistic effect of NELL1 and adipose-derived stem cells on promoting bone formation in osteogenesis imperfecta treatment.
Liu Y; Ju M; Wang Z; Li J; Shao C; Fu T; Jing Y; Zhao Y; Lv Z; Li G
Biomed Pharmacother; 2020 Aug; 128():110235. PubMed ID: 32454289
[TBL] [Abstract][Full Text] [Related]
19. Distribution of single-cell expanded marrow derived progenitors in a developing mouse model of osteogenesis imperfecta following systemic transplantation.
Li F; Wang X; Niyibizi C
Stem Cells; 2007 Dec; 25(12):3183-93. PubMed ID: 17823236
[TBL] [Abstract][Full Text] [Related]
20. Local transplantation is an effective method for cell delivery in the osteogenesis imperfecta murine model.
Pauley P; Matthews BG; Wang L; Dyment NA; Matic I; Rowe DW; Kalajzic I
Int Orthop; 2014 Sep; 38(9):1955-62. PubMed ID: 24384938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
